Logo image
Metastatic human hepatoblastoma cells exhibit enhanced tumorigenicity, invasiveness and a stem cell-like phenotype
Journal article   Open access   Peer reviewed

Metastatic human hepatoblastoma cells exhibit enhanced tumorigenicity, invasiveness and a stem cell-like phenotype

Raoud Marayati, Janet R. Julson, Laura V. Bownes, Colin H. Quinn, Sara C. Hutchins, Adele P. Williams, Hooper R. Markert, Andee M. Beierle, Jerry E. Stewart, Anita B. Hjelmeland, …
Journal of pediatric surgery, Vol.57(6), pp.1018-1025
06/01/2022
DOI: 10.1016/j.jpedsurg.2022.01.063
PMCID: PMC9119922
PMID: 35300860
url
https://doi.org/10.1016/j.jpedsurg.2022.01.063View
Published (Version of record) Open Access

Abstract

Metastatic hepatoblastoma continues to pose a significant treatment challenge, primarily because the precise mechanisms involved in metastasis are not fully understood, making cell lines and preclinical models that depict the progression of disease and metastasis-related biology paramount. We aimed to generate and characterize a metastatic hepatoblastoma cell line to create a model for investigation of the molecular mechanisms associated with metastasis. Using a murine model of serial tail vein injections of the human hepatoblastoma HuH6 cell line, non-invasive bioluminescence imaging, and dissociation of metastatic pulmonary lesions, we successfully established and characterized the metastatic human hepatoblastoma cell line, HLM_3. The HLM_3 cells exhibited enhanced tumorigenicity and invasiveness, both in vitro and in vivo compared to the parent HuH6 cell line. Moreover, HLM_3 metastatic hepatoblastoma cells exhibited a stem cell-like phenotype and were more resistant to the standard chemotherapeutic cisplatin. This newly described metastatic hepatoblastoma cell line offers a novel tool to study mechanisms of tumor metastasis and evaluate new therapeutic strategies for metastatic hepatoblastoma.
Cisplatin Hepatoblastoma Metastases Stem cell

Details

Metrics

Logo image